Key facts
- Suvera’s last known valuation is $38.5M (Feb 2025).
- It has raised $16.8M; the latest was Accelerator/Incubator in May 2025.
- Notable investors include Ascension, Morningside Group, Calm/Storm Ventures, The NHS Innovation Accelerator, Millennium Technology Value Partners — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Suvera
- ·The full record, as it builds
Funding rounds
No funding rounds for Suvera are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Suvera
Developer of a virtual healthcare platform designed to deliver healthcare that keeps people in good health. The company's platform facilitates general practices to virtually manage patients with long-term conditions such as hypertension, diabetes, asthma, chronic obstructive pulmonary disease, depression, and anxiety, enabling patients to reach their health achievements.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Employees
- 65
- Website
- suvera.com/
- Ownership
- Privately Held (backing)
Suvera doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Suvera shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Suvera in its N-PORT filings yet. We sweep new filings monthly.